Crossmark

Impact of bariatric surgery on metabolic-dysfunction associated fatty liver disease in diabetic and non-diabetic patients: a cohort study

Published Online: 2025-12-07

Authors

Sistanizad, Mohammad https://orcid.org/0000-0002-7836-6411
Taherpour, Niloufar https://orcid.org/0000-0002-8336-0671
Alibeigi, Peyman https://orcid.org/0000-0001-9775-3479
Sadeghi, Soheila https://orcid.org/0000-0002-6229-3430
Shamizadehkalkhoran, Mojan

Moradi, Omid https://orcid.org/0000-0001-5754-535X
License Information

Text and Data Mining valid from 2025-12-07

Version of Record valid from 2026-01-12
More Information

Article History

Received: 13 September 2025

Accepted: 1 December 2025

First Online: 7 December 2025

Declarations

:

: The study was approved by the board of ethics committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran and received ethical approval code (IR.SBMU.RETECH.REC.1402.194). The study was conducted in accordance with the Declaration of Helsinki. Data was extracted from a local database registry on bariatric surgery and written informed consent was obtained from each patient before including to this registry. No identifiable personal information from any patients is included in this study. The institutional review board (IRB) classified the study as minimal risk research because we waived the need for secondary informed consent from the participants.

: Not applicable.

: The authors declare no competing interests.

Document is current